These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Therapeutic targets in osteoarthritis: from today to tomorrow with new imaging technology. Pelletier JP; Martel-Pelletier J Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii79-82. PubMed ID: 14532156 [No Abstract] [Full Text] [Related]
4. Prescription of glucosamine for osteoarthritis: does it work and is it safe? Wollheim FA Nat Clin Pract Rheumatol; 2007 Jul; 3(7):364-5. PubMed ID: 17534290 [No Abstract] [Full Text] [Related]
5. Hand osteoarthritis: new insights. Gabay O; Gabay C Joint Bone Spine; 2013 Mar; 80(2):130-4. PubMed ID: 22871418 [TBL] [Abstract][Full Text] [Related]
6. The importance of synovial inflammation in osteoarthritis: current evidence from imaging assessments and clinical trials. Wang X; Hunter DJ; Jin X; Ding C Osteoarthritis Cartilage; 2018 Feb; 26(2):165-174. PubMed ID: 29224742 [TBL] [Abstract][Full Text] [Related]
7. Anti-TNF scintigraphy to assess TNF-α-associated joint inflammation in rheumatoid arthritis and osteoarthritis. Hermann J; Lipp RW; Dunzinger A; Spreizer C; Schaffler G; Kvaternik H; Ofner P; Graninger W Clin Exp Rheumatol; 2014; 32(4):614. PubMed ID: 24959905 [No Abstract] [Full Text] [Related]
8. Plain radiography or magnetic resonance imaging (MRI): Which is better in assessing outcome in clinical trials of disease-modifying osteoarthritis drugs? Summary of a debate held at the World Congress of Osteoarthritis 2014. Eckstein F; Le Graverand MP Semin Arthritis Rheum; 2015 Dec; 45(3):251-6. PubMed ID: 26142321 [TBL] [Abstract][Full Text] [Related]
9. Review: the utility of magnetic resonance imaging for assessing structural damage in randomized controlled trials in rheumatoid arthritis. American College of Rheumatology Rheumatoid Arthritis Clinical Trials Task Force Imaging Group and Outcome Measures in Rheumatology Magnetic Resonance Imaging Inflammatory Arthritis Working Group Arthritis Rheum; 2013 Oct; 65(10):2513-23. PubMed ID: 23840013 [No Abstract] [Full Text] [Related]
10. Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs. Verbruggen G; Goemaere S; Veys EM Clin Rheumatol; 2002 Jun; 21(3):231-43. PubMed ID: 12111630 [TBL] [Abstract][Full Text] [Related]
11. A perspective on arthritis. Conn DL J Med Assoc Ga; 2002; 91(1):4-5. PubMed ID: 11938629 [No Abstract] [Full Text] [Related]
13. Efficacy and side effect of curcumin for the treatment of osteoarthritis: A meta-analysis of randomized controlled trials. Wu J; Lv M; Zhou Y Pak J Pharm Sci; 2019 Jan; 32(1):43-51. PubMed ID: 30772789 [TBL] [Abstract][Full Text] [Related]
14. Prospects for disease modification in osteoarthritis. Abramson SB; Attur M; Yazici Y Nat Clin Pract Rheumatol; 2006 Jun; 2(6):304-12. PubMed ID: 16932709 [TBL] [Abstract][Full Text] [Related]
16. Assessment and follow-up of osteoarthritis of the limbs--outcome measures. Lequesne M Schweiz Med Wochenschr Suppl; 1996; 80():8S-9S. PubMed ID: 8795115 [No Abstract] [Full Text] [Related]
17. [Erosive or inflammatory osteoarthritis: the great unknown]. Contreras Blasco MA Med Clin (Barc); 2007 Jul; 129(7):262-6. PubMed ID: 17683709 [No Abstract] [Full Text] [Related]
18. How can one develop disease-modifying drugs in osteoarthritis? Dougados M Curr Rheumatol Rep; 2005 Mar; 7(1):22-8. PubMed ID: 15760577 [TBL] [Abstract][Full Text] [Related]
19. Lessons learned from nine clinical trials of disease-modifying osteoarthritis drugs. Brandt KD; Mazzuca SA Arthritis Rheum; 2005 Nov; 52(11):3349-59. PubMed ID: 16258927 [No Abstract] [Full Text] [Related]